AvantorSTU:AVG +2.89%61 EBITDA Margin % is 12.86% as of Mar. 2026, which is 10% below its 10-year median of 14.23. GuruFocus rates STU:AVG with a GF Score™ of 61/100 and a GF Value™ of €16.15 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Avantor ranks worse than 59.19% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Avantor's EBITDA for the
three
months ended in Mar. 2026 was €176 Mil. Avantor's Revenue for the
three
months ended in Mar. 2026 was €1,368 Mil. Therefore, Avantor's EBITDA margin for the quarter that ended in Mar. 2026 was 12.86%.
Avantor (STU:AVG) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Avantor EBITDA Margin % Related Terms
Avantor EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Avantor's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:AVG vs TFX, RGEN, STVN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Avantor's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avantor EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avantor's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Avantor's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avantor (STU:AVG) has a EBITDA Margin % of 12.86% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Avantor and its competitors. This is 10% below median its historical median of 14.23. According to the industry distribution chart, Avantor ranks #483 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 59.2%.
Is Avantor's EBITDA Margin % too high?
Avantor's current EBITDA Margin % of 12.86% is 10% below median its 10-year median of 14.23. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Avantor's value of 12.86% is 72% above this industry median. Based on the distribution chart, Avantor ranks #483 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Avantor has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Avantor's EBITDA Margin % compare to TFX and RGEN?
According to the Medical Devices & Instruments industry distribution chart, Avantor ranks #483 out of 816 companies for EBITDA Margin %. This places Avantor in the lower half of its industry. The industry median EBITDA Margin % is 7.48. Avantor's value of 12.86% is 72% above this benchmark. While the company's 10-year median is 14.23 vs. the industry median of 7.48, Avantor has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avantor's current EBITDA Margin % of 12.86% is 72% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Avantor and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avantor's current EBITDA Margin % is 12.86%, which is 10% below median its own 10-year median of 14.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avantor stock overvalued right now?
Based on GuruFocus' analysis, Avantor (STU:AVG) is currently considered Possible Value Trap. The stock's GF Value™ is €16.15, compared to a current price of €8.49 — trading 47.5% below its estimated fair value. The current EBITDA Margin % is 12.86%, which is 10% below median its 10-year median of 14.23 and 72% above the Medical Devices & Instruments industry median of 7.48. Avantor's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Avantor (STU:AVG), the current EBITDA Margin % is 12.86% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avantor (STU:AVG) Overvalued in 2026?
Based on GuruFocus' analysis, Avantor stock appears to be undervalued.
The current stock price of €8.49 is trading 47.5% below its estimated GF Value™ of €16.15.
GuruFocus considers Avantor to be Possible Value Trap.
Key valuation signals for STU:AVG:
EBITDA Margin %: 12.86% (10% below median its 10-year median of 14.23)
GF Value™: €16.15 vs. price of €8.49 (47.5% below fair value)
Industry Position: 72% above the Medical Devices & Instruments median (#483 of 816)
No single metric tells the full story. See the STU:AVG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
61GF Score
Get the complete analysis for STU:AVG
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:AVG has been successfully added to your 
